Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 3100Neoplasms 2446Carcinoma, Non-Small-Cell Lung 1865Prostatic Neoplasms 1629Colorectal Neoplasms 1424Lung Neoplasms 1300Multiple Myeloma 930Neoplasm Metastasis 926Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 851Ovarian Neoplasms 803Melanoma 786Carcinoma, Hepatocellular 743Stomach Neoplasms 640Brain Neoplasms 640Recurrence 635Squamous Cell Carcinoma of Head and Neck 631Head and Neck Neoplasms 614Glioblastoma 569Lymphoma 543Uterine Cervical Neoplasms 541Triple Negative Breast Neoplasms 505Precursor Cell Lymphoblastic Leukemia-Lymphoma 498Carcinoma, Renal Cell 497Hematologic Neoplasms 467Urinary Bladder Neoplasms 462Endometrial Neoplasms 462Colonic Neoplasms 439Sarcoma 437Lymphoma, Non-Hodgkin 437

Interventions

liposomal doxorubicin 1Zidovudine 1Vincristine 1Valganciclovir 1Sirolimus 1Rituximab 1Prednisone 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Macular dystrophy, corneal type 1 × 1 year × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡